麦澜德股价涨5.05%，华夏基金旗下1只基金位居十大流通股东，持有70.15万股浮盈赚取156.44万元

Group 1 - The core viewpoint of the article highlights the recent performance of Mcland, which saw a 5.05% increase in stock price, reaching 46.37 CNY per share, with a total market capitalization of 4.637 billion CNY [1] - Mcland specializes in the research, development, production, sales, and services related to pelvic floor and postpartum rehabilitation products, with its main revenue sources being pelvic rehabilitation products (36.98%), reproductive rehabilitation products (33.10%), consumables and accessories (24.32%), sports rehabilitation products (2.77%), and other products (2.84%) [1] Group 2 - From the perspective of Mcland's top circulating shareholders, Huaxia Fund holds a significant position, with its Huaxia Stable Growth Mixed Fund reducing its holdings by 550,500 shares, now owning 701,500 shares, which accounts for 1.9% of circulating shares [2] - The Huaxia Stable Growth Mixed Fund has achieved a year-to-date return of 22.33%, ranking 284 out of 8,891 in its category, and a one-year return of 59.99%, ranking 784 out of 8,137 [2]